Status:

ACTIVE_NOT_RECRUITING

Improving the Activation Level of Diabetic Individuals

Lead Sponsor:

Dokuz Eylul University

Conditions:

Diabetes Mellitus (DM)

Type 2 Diabetes Mellitus (T2DM)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study was planned to determine the activation levels of diabetic individuals and to improve the activation level. The study, planned as a descriptive and experimental type, is an attempt to incre...

Detailed Description

Type 2 diabetes, which is rapidly increasing in prevalence worldwide and poses a global threat, is a complex, chronic condition that requires ongoing medical care with multifactorial risk reduction st...

Eligibility Criteria

Inclusion

  • Having diabetes for 1 year or more, Able to read and write Turkish, Having no visual, auditory, perceptual or any other physical disability, Having the physical, mental and emotional capacity to participate in self-care activities, Having no language problems, Accepting to participate voluntarily in the study.

Exclusion

  • Individuals with any mental/cognitive problems,
  • Those who cannot read or write,
  • Those with visual, hearing, perception or any physical disability,
  • Those who are immobile or bedridden,
  • Those who do not have the ability to participate in their own self-care activities,
  • Those who do not want to participate in the study were excluded from the sample.

Key Trial Info

Start Date :

January 2 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 25 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06973954

Start Date

January 2 2025

End Date

August 25 2025

Last Update

May 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dokuz Eylul University Health Sciences Institute Izmir

Izmir, Turkey (Türkiye)